International Biotechnology Trust PLC Concert Pharmaceuticals, Inc. Transaction History

International Biotechnology Trust PLC

  • $295 Million
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022
BUY
$4.27 - $7.2 $846,271 - $1.43 Million
198,190 Added 7593.49%
200,800 $1.35 Million
Q2 2022

Aug 16, 2022
BUY
$2.8 - $6.36 $7,307 - $16,599
2,610 New
2,610 $620 Million
Q3 2019

Nov 14, 2019
SELL
$5.88 - $12.35 $411,600 - $864,500
-70,000 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$9.44 - $13.12 $660,800 - $918,400
70,000 New
70,000 $839,000

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CONCERT PHARMACEUTICALS, INC.

CNCE Quotes by TradingView
  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email